华虹公司公告称，因筹划发行股份购买资产并募集配套资金事项，公司股票自2025年8月18日开市起停 牌。重组预案披露前20个交易日（2025年7月21日至8月15日），公司股价累计涨幅48.31%，剔除大盘 和同行业板块因素影响后，累计涨跌幅超20%。公司提示风险，中国证监会可能调查股价异动，若涉嫌 内幕交易，本次交易或暂停、终止或取消。 ...

Group 1 - The company plans to issue shares to acquire 99.42% equity of Shandong Hongjitang Pharmaceutical Group Co., Ltd. from 38 counterparties, including Linuo Investment Holding Group Co., Ltd. and Linuo Group Co., Ltd. [1] - The company intends to raise supporting funds by issuing shares to no more than 35 qualified specific objects as part of the transaction [1] - The announcement includes a revised draft of the "Report on Issuing Shares to Purchase Assets and Raising Supporting Funds and Related Transactions" [1] Group 2 - The revised report updates the stock issuance price and quantity for the asset purchase, as well as the raised supporting funds [2] - The decision-making process and approval status of the transaction have been updated in the report [2] - The financial status and profitability analysis of the target company have been improved and updated in the management discussion and analysis section [2]